巨噬細(xì)胞炎性蛋白3α(MIP3a)活性蛋白
Active Macrophage Inflammatory Protein 3 Alpha (MIP3a)
CCL20; CKb4; LARC; MIP3-A; SCYA20; ST38; Small Inducible Cytokine Subfamily A(Cys-Cys)Member 20; Beta-Chemokine Exodus-1; Liver And Activation-Regulated Chemokine
- 編號APA095Hu02
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)8.5
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 2074 ¥ 5184 ¥ 10368 ¥ 31104 ¥ 77760
- 欲了解實(shí)際交易價(jià)格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
Macrophage Inflammatory Protein 3 Alpha (MIP3a) also known as Chemokine (C-C motif) ligand 20 (CCL20) or liver activation regulated chemokine (LARC) is a small cytokine belonging to the CC chemokine family. It is strongly chemotactic for lymphocytes and weakly attracts neutrophils. MIP3a is implicated in the formation and function of mucosal lymphoid tissues via chemoattraction of lymphocytes and dendritic cells towards the epithelial cells surrounding these tissues. It is expressed in several tissues such as peripheral blood lymphocytes, lymph nodes, liver, appendix, fetal lung. Expression of MIP3a can be induced by microbial factors such as lipopolysaccharide (LPS), and inflammatory cytokines such as tumor necrosis factor and interferon-γ, and down-regulated by IL-10. Besides, lnterleukin 1 Alpha (IL1a) has been identified as an interactor of MIP3a, thus a binding ELISA assay was conducted to detect the interaction of recombinant human MIP3a and recombinant human IL1a. Briefly, MIP3a were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to IL1a-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-MIP3a pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450nm immediately. The binding activity of MIP3a and IL1a was shown in Figure 1, and this effect was in a dose dependent manner, the EC50?for this effect is 0.676 ug/mL.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA095Hu01 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA095Hu01 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA095Hu02 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA095Hu02 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA095Hu01 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)多克隆抗體 | WB; IHC; ICC; IP. |
PAA095Hu02 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)多克隆抗體 | WB; IHC; ICC; IP. |
LAA095Hu71 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
LAA095Hu81 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
MAA095Hu22 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu23 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu24 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu25 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu27 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu21 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)單克隆抗體 | WB,IHC |
SEA095Hu | 巨噬細(xì)胞炎性蛋白3α(MIP3a)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA095Hu | 巨噬細(xì)胞炎性蛋白3α(MIP3a)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA095Hu01 | 巨噬細(xì)胞炎性蛋白3α(MIP3a)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動(dòng)手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Medicine (Baltimore). | Increased Serum Levels of Macrophage Inflammatory Protein-3α and Cystatin A Predict a Poor Prognosis of Nasopharyngeal Carcinoma [Pubmed:25396333] |
Cancer | Serum chemokine network correlates with chemotherapy in non-small cell lung cancer [PubMed: 25976768] |
American Journal of?Cancer?Research | CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis. [pubmed:28560063] |
Biological Research | In vitro chemokine (CC motif) receptor 6-dependent non-inflammatory chemotaxis during spermatogenesis [10.1186:s40659-018-0161-z] |
BioMed Research International | Indoleamine 2, 3-Dioxygenase (IDO) Regulates Th17/Treg Immunity in Experimental IgA Nephropathy [] |